Benvenue Medical Secures $25 Million Series D Financing (press release)
Spine Company is Well-Poised for Rapid U.S. and Global Sales in Fusion and VCF Products
SANTA CLARA, Calif., June 28, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced it completed a $25 million Series D round of financing. The spine company intends to use the proceeds to sustain global commercialization of its three breakthrough minimally invasive products to treat degenerative disc disease (DDD) with spinal fusion and vertebral compression fractures (VCFs...
The Orthopedics Industry 
